GlassScriptPhysician profile
William Preston Buchanan
NPI 1225146210
$3,111.01
in general payments reported to CMS, 2019-2025
31 companies · $1,928 in 2025
The $1,928 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $100 · 2020: $18.78 · 2021: $104 · 2022: $360 · 2023: $121 · 2024: $478 · 2025: $1,928.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,528.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,528.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $369.46 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novartis Pharmaceuticals Corporation | $314.10 | 2024-2025 | |
| Abbott Laboratories | $285.20 | 2021-2025 | Amplatzer Amulet |
| Amgen INC. | $275.77 | 2022-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $198.55 | 2021-2025 | Cds - Mct/Cem Monitoring, Accolade Sr, Lux-Dx Insertable Cardiac Monitor |
| E.R. Squibb & Sons, L.L.C. | $190.25 | 2020-2025 | Camzyos, Eliquis |
| W. L. Gore & Associates, INC. | $167.63 | 2025 | Gore Viabahn Vbx Balloon Expandable Endo |
| Bridgebio Pharma, INC. | $142.28 | 2025 | Attruby |
| Novo Nordisk INC | $132.91 | 2025 | Wegovy |
| Abiomed | $100.01 | 2023-2025 | Impella |
| Penumbra, INC. | $100.00 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $96.67 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $96.09 | 2022-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $95.35 | 2021-2025 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $87.38 | 2025 | Lokelma, Farxiga |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $57.76 | 2025 | |
| Alnylam Pharmaceuticals INC. | $43.90 | 2025 | Amvuttra |
| Edwards Lifesciences Corporation | $43.15 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.07 | 2025 | Jardiance |
| Baxter Healthcare | $40.26 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Inari Medical, INC. | $37.19 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Pfizer INC. | $36.76 | 2025 | |
| Tactile Systems Technology INC | $29.22 | 2025 | Flexitouch Plus, Nimbl |
| Corvista Health, INC. | $22.67 | 2025 | Corvista System |
| Cashflow Solutions, LLC | $20.35 | 2025 | Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White |
| Inspire Medical Systems, INC. | $19.81 | 2025 | Inspire |
| Medtronic, INC. | $16.54 | 2025 | Mycarelink |
| Lantheus Medical Imaging, INC. | $16.09 | 2025 | |
| Vital Connect, INC | $13.51 | 2024 | Vitalpatch Rtm |
| Terumo Medical Corporation | $11.08 | 2021 | |
| Vivaquant INC, Dba Rhythm Express | $10.00 | 2025 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Buchanan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.